Category: General

Beyond the Checklist: Why Effective Conflicts of Interest Programs Are Central to Ethics and Compliance

Conflicts of interest are not abstract compliance niceties. They are serious risks to integrity that, if left unidentified or unmitigated, can erode employee trust, compromise decision-making, and expose organizations to regulatory enforcement, litigation, and reputational harm. Recent high-profile scandals involving relationships between supervisors and subordinates have underscored how personal conflicts can quickly morph into enterprise-wide compliance failures when controls, oversight, and ethical culture are weak....

The Tilt Toward Corporate Voluntary Disclosures

Companies often face difficult choices when it comes to deciding on whether to disclose corporate misconduct to the government.  Over the years, more counsel have embraced the idea of sitting tight after uncovering and remediating misconduct (unless the company is subject to mandatory disclosure requirements). Admittedly, I have been aware of situations where that strategy was appropriate.  The likelihood of detection was low and the...

UFLPA Enforcement: When a “Red Light” Turns Yellow

The Uyghur Forced Labor Prevention Act (UFLPA) was designed to be one of the toughest trade enforcement statutes ever enacted by Congress. Passed with near-unanimous bipartisan support in late 2021, the law created a rebuttable presumption that goods made wholly or in part in China’s Xinjiang region—or by entities linked to forced labor there—are prohibited from entering the United States. In theory, the statute was...

DOJ’s False Claims Act Bread and Butter — The Healthcare Industry (Part II of II)

Healthcare fraud continues to plague providers, managed care, and drug companies.  $5.7 billion of the $6.8 billion recovered by DOJ was generated from the healthcare industry.  There is a bottomless pit of possible targets.  DOJ’s only constraint is its resources assigned to prosecute FCA cases in the healthcare industry.  DOJ focused on three major areas: Managed Care, Prescription Drugs, and Medically Unnecessary Care.  In Managed...

DOJ’s 2025 False Claims Act Report Cites $6.8 Billion in Recoveries  (Part I of II)

The Justice Department has increased False Claims Act prosecutions, reflecting a continued focus on healthcare fraud and a new initiative on trade fraud.  DOJ announced the largest annual recovery figure in the FCA’s history — $6.8 billion in settlements and recoveries.  FCA whistleblowers filed a record number of new cases — 1,297 lawsuits and the government initiated 401 investigations.  Since 1986, DOJ has recovered a...

Reviewing the 5 Major AI Risks (Part II of II)

Here are the five primary risk areas when a company uses AI in a supportive or assistance-based role as opposed to an algorithmic-based use case. 1. Data Protection and Cybersecurity: Internal AI use cases may involve chatbots, drafting of documents, emails, and other deliverables (e.g. slide decks).  To the extent employees incorporate sensitive data (e.g. confidential, personal or regulated data) into AI vendor tools, such...

Soothing the AI-Risk Hysteria: A Focused Approach to AI Risks (Part I of II)

From my perspective, hopefully a reasonable one, there is a little too much AI-Risk Hype.  Not to belittle the experts or ignore potential risk concerns but this is getting a little carried away.  The compliance industry appears to be taken over by AI-this and AI-that.  Third party risk bleeds into major AI risks, corporate governance needs to incorporate AI risks, and policies and procedures have...

Trade Enforcement: A Look Back (Part I of II)

Typically, I enjoy the New Year (notwithstanding Larry David’s rule of no New Year wishes past 15 days of the New Year).  It is important to look back, assess and identify trends; after all, what better marker than annual reviews. The most significant compliance and enforcement issue remains trade enforcement — sanctions and export controls.  In the second posting, I want to focus on the...

BIS Imposes $1.5 Million Penalty on Exyte for Unlicensed In-Country Transfers to SMIC

On January 7, 2026, the U.S. Department of Commerce’s Bureau of Industry and Security (“BIS”) issued an Order resolving an administrative enforcement action against Exyte Management GmbH, a Germany-based company headquartered in Stuttgart, in connection with alleged violations of the Export Administration Regulations (“EAR”). The action arose from conduct occurring between March 2021 and March 2022 and involved in-country transfers of items subject to the...